Please provide your email address to receive an email when new articles are posted on . In the United States, the annual rate of growth in incident patients with end-stage kidney disease has slowed.

This Rare Disease Day, observed on Feb. 28 worldwide, the American Kidney Fund is committed to improving the understanding of ...

A research team led by Prof. Dr. Christian Hinze, senior physician at the MHH Clinic for Kidney and Hypertension Diseases at ...

Heart failure patients treated with finerenone (Kerendia; Bayer AG) are more likely to have an early decline in kidney function than those treated with placebo, but the decline should not be construed ...

Pregnancy can have a big impact on a woman’s body. For Marrian Bell, 35, it affected her kidney function as she fought to ...

Chlorthalidone appears as effective as hydrochlorothiazide in slowing progression to chronic kidney disease among patients with hypertension. Kidney function decline occurs no faster when patients ...

Patients with immunoglobin A nephropathy who reached complete remission of proteinuria with sparsentan had greater eGFR ...

Medically reviewed by David Ozeri, MD Complement 3 glomerulopathy (C3G) is a rare kidney disorder—in many cases, the exact ...

New study findings “are critically important in patient counseling and surgical planning, particularly for patients with risk factors for renal deterioration,” according to investigators. A lower ...

At the recent signing of the Trump administration’s kidney care executive order, the excitement in the room was palpable. For me, the patients on stage defined the moment as they described their ...